Verve Therapeutics
VERV
#6558
Rank
A$0.83 B
Marketcap
$9.82
Share price
-0.16%
Change (1 day)
-32.74%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.76

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.85. In 2022 the company made an earnings per share (EPS) of -$4.47 a decrease over its 2021 EPS that were of -$3.87.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.766.49%
2022-$4.4715.54%
2021-$3.8761.32%
2020-$2.40